Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6326027 | 7101601 | F | 1 | 6326027-0 | 20090304 | 20090805 | 20090820 | EXP | DSJ-2009-09566 | DAIICHI SANKYO INC. | 77 | YR | M | N | 75 | KG | 20090817 | 20090404 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6326027 | 1012124993 | PS | OLMETEC (OLMESARTAN MEDOXOMIL) (TABLET) (OLMESARTAN MEDOXOMIL) | 2 | ORAL | 10 MG (10 MG, 1 IN 1 D),PER ORAL | D | D | 21286 | ||
| 6326027 | 1012164008 | C | VERAPAMIL HYDROCHLORIDE | 1 | |||||||
| 6326027 | 1012164013 | C | ASPIRIN | 1 | |||||||
| 6326027 | 1012164014 | C | BASEN (VOGLIBOSE) (VOGLIBOSE) | 2 | |||||||
| 6326027 | 1012164015 | C | WARFARIN SODIUM | 1 | |||||||
| 6326027 | 1012164016 | C | PRONON (PROPAFENONE HYDROCHLORIDE)(PROPAFENONE HYDROCHLORIDE) | 2 | |||||||
| 6326027 | 1012164017 | C | CIBENOL (CIBENZOLINE SUCCINATE)(CIBENZOLINE SUCCINATE) | 2 | |||||||
| 6326027 | 1012164018 | C | CARVEDILOL | 1 | |||||||
| 6326027 | 1012164019 | C | NORVASC | 1 | |||||||
| 6326027 | 1012164020 | C | DAONIL (GLIBENCLAMIDE) (GLIBENCLAMIDE) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6326027 | 1012124993 | ESSENTIAL HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6326027 | DE |
| 6326027 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6326027 | AMYOTROPHIC LATERAL SCLEROSIS |
| 6326027 | DYSPHAGIA |
| 6326027 | DYSPHONIA |
| 6326027 | INTENTIONAL SELF-INJURY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6326027 | FGN |
| 6326027 | HP |
| 6326027 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6326027 | 1012124993 | 20070119 | 20090404 |